Avoro Capital Advisors LLC — 13F Holdings

2026 Q3  ·  31 Positions

2026 Q3 Portfolio Activity

In 2026 Q3, Avoro Capital Advisors LLC maintained a portfolio of 31 distinct positions. The most significant new addition was DAMORA THERAPEUTICS INC, now representing 0.83% of the total fund value. The fund also reduced its exposure to CELCUITY INC by 55.9%.
Position History hover any row below to update
Loading…
Avoro Capital Advisors LLC New York, NY Hedge Fund / Life Sciences Specialist AUM $9,691M
PCA Score Concentration Risk
Risk ENB
Total Positions
31
Quarter
2026 Q3
Top Holding
UTHR (15.4%)
Top 10 Concentration
83.3%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-31 of 31

Avoro Capital Advisors LLC Full Holdings List — 2026 Q3

Stock History Sector / Type Port % Prev % Rank / Prev Conviction
Freshness
Change % Change Influence Shares Mkt Value Avg Cost Price Held 1st Owned Source Source Date Date Reported
UTHR
UNITED THERAPEU...
Healthcare 15.41% 13.52% #1
Prev: #1
6.5
—
-22,222 -0.8%
P
S
2,755,555 $1,493,207,699 2020 Q4 13F Filing 2026-09-30 2026-11-16
ASND
ASCENDIS PHARMA...
Healthcare 11.87% 12.24% #2
Prev: #2
6.0
—
-61,111 -1.2%
P
S
5,050,000 $1,150,541,500 2016 Q3 13F Filing 2026-09-30 2026-11-16
KRYS
KRYSTAL BIOTECH...
Healthcare 9.91% 9.64% #3
Prev: #3
6.0
—
no change no change
P
S
2,888,888 $960,728,593 2021 Q4 13F Filing 2026-09-30 2026-11-16
ARGX
ARGENX SE
Healthcare 9.89% 8.33% #4 1
Prev: #5
5.5
—
no change no change
P
S
1,000,000 $958,910,000 2017 Q2 13F Filing 2026-09-30 2026-11-16
MDGL
MADRIGAL PHARMA...
Healthcare 9.53% 8.84% #5 1
Prev: #4
5.3
—
no change no change
P
S
1,833,333 $923,926,499 2018 Q2 13F Filing 2026-09-30 2026-11-16
KYMR
KYMERA THERAPEU...
Healthcare 8.62% 7.70% #6 1
Prev: #7
4.4
—
no change no change
P
S
7,474,747 $835,601,967 2020 Q3 13F Filing 2026-09-30 2026-11-16
ARWR
ARROWHEAD PHARM...
Healthcare 7.43% 8.31% #7 1
Prev: #6
3.5
—
-355,555 -3.1%
P
S
11,000,000 $719,950,000 2014 Q4 13F Filing 2026-09-30 2026-11-16
RVMD
REVOLUTION MEDI...
Healthcare 4.54% 3.86% #8
Prev: #8
2.3
—
-152,000 -6.6%
P
S
2,145,000 $440,282,700 2020 Q1 13F Filing 2026-09-30 2026-11-16
CYTK
CYTOKINETICS IN...
Healthcare 3.33% 3.82% #9
Prev: #9
1.8
—
-99,999 -2.0%
P
S
4,900,000 $322,959,000 2016 Q2 13F Filing 2026-09-30 2026-11-16
DFTX
DEFINIUM THERAP...
Healthcare 2.77% 3.04% #10 3
Prev: #13
1.6
—
-138,888 -1.9%
P
S
7,050,000 $268,323,000 2026 Q1 13F Filing 2026-09-30 2026-11-16
GPCR
STRUCTURE THERA...
Healthcare 2.12% 3.16% #11
Prev: #11
1.8
—
no change no change
P
S
6,555,555 $204,992,205 2023 Q3 13F Filing 2026-09-30 2026-11-16
XENE
XENON PHARMACEU...
Healthcare 2.11% 3.13% #12
Prev: #12
1.3
—
-277,777 -4.8%
P
S
5,500,000 $204,545,000 2018 Q2 13F Filing 2026-09-30 2026-11-16
VERA
VERA THERAPEUTI...
Healthcare 1.88% 2.21% #13 2
Prev: #15
1.3
—
-88,888 -1.6%
P
S
5,635,000 $181,954,150 2024 Q1 13F Filing 2026-09-30 2026-11-16
QURE
UNIQURE NV
Healthcare 1.68% 2.78% #14
Prev: #14
1.7
—
no change no change
P
S
6,727,777 $162,543,092 2015 Q1 13F Filing 2026-09-30 2026-11-16
CELC
CELCUITY INC
Healthcare 1.23% 3.19% #15 5
Prev: #10
0.5
—
-1,900,000 -55.9%
P
S
1,500,000 $119,280,000 2025 Q4 13F Filing 2026-09-30 2026-11-16
TSHA
TAYSHA GENE THE...
Healthcare 1.20% 1.46% #16
Prev: #16
1.5
—
no change no change
P
S
23,888,888 $116,338,885 2023 Q3 13F Filing 2026-09-30 2026-11-16
OCUL
OCULAR THERAPEU...
Healthcare 0.98% 1.11% #17
Prev: #17
0.9
—
-159,700 -1.3%
P
S
12,380,300 $94,956,901 2024 Q1 13F Filing 2026-09-30 2026-11-16
N/A
DAMORA THERAPEU...
Unknown 0.83% — #18
Prev: #—
3.8
—
3,783,000 —
NEW
3,783,000 $80,502,240 — 13F Filing 2026-09-30 2026-11-16
COAG
HEMAB THERAPEUT...
Healthcare 0.60% 0.63% #19
Prev: #19
0.7
—
-32,778 -1.7%
P
S
1,892,372 $58,360,752 2026 Q2 13F Filing 2026-09-30 2026-11-16
VRDN
VIRIDIAN THERAP...
Healthcare 0.53% 0.41% #20 1
Prev: #21
1.2
—
no change no change
P
S
2,500,000 $51,475,000 2025 Q4 13F Filing 2026-09-30 2026-11-16
SEPN
SEPTERNA INC
Healthcare 0.52% 0.40% #21 1
Prev: #22
0.7
—
-37,500 -2.8%
P
S
1,300,000 $50,869,000 2024 Q4 13F Filing 2026-09-30 2026-11-16
ABVX
ABIVAX SA
Healthcare 0.50% — #22
Prev: #—
3.7
—
488,000 —
NEW
488,000 $48,321,760 2026 Q3 13F Filing 2026-09-30 2026-11-16
SCTX
SCRIBE THERAPEU...
Healthcare 0.49% — #23
Prev: #—
3.7
—
2,598,973 —
NEW
2,598,973 $47,834,098 2026 Q3 13F Filing 2026-09-30 2026-11-16
SNSE
FAETH THERAPEUT...
Healthcare 0.43% 0.32% #24
Prev: #24
0.7
—
-34,039 -2.4%
P
S
1,410,000 $41,933,400 2026 Q2 13F Filing 2026-09-30 2026-11-16
GHRS
GH RESEARCH PLC
Healthcare 0.43% 0.43% #25 5
Prev: #20
0.7
—
-30,000 -1.7%
P
S
1,770,000 $41,559,600 2025 Q4 13F Filing 2026-09-30 2026-11-16
N/A
BIOHAVEN LTD
Unknown 0.38% — #26
Prev: #—
3.7
—
2,750,000 —
NEW
2,750,000 $36,712,500 — 13F Filing 2026-09-30 2026-11-16
AVTX
AVALO THERAPEUT...
Healthcare 0.38% 0.39% #27 4
Prev: #23
0.7
—
44,444 1.9%
P
S
2,377,777 $36,451,321 2026 Q1 13F Filing 2026-09-30 2026-11-16
BRVE
BRAVEHEART BIO ...
Healthcare 0.26% — #28
Prev: #—
3.6
—
1,255,000 —
NEW
1,255,000 $25,351,000 2026 Q3 13F Filing 2026-09-30 2026-11-16
WHWK
WHITEHAWK THERA...
Healthcare 0.11% 0.12% #29 4
Prev: #25
1.0
—
no change no change
P
S
2,849,402 $10,713,752 2021 Q3 13F Filing 2026-09-30 2026-11-16
LXEO
LEXEO THERAPEUT...
Healthcare 0.02% 0.06% #30 4
Prev: #26
0.0
—
-964,189 -64.7%
P
S
525,000 $1,774,500 2025 Q4 13F Filing 2026-09-30 2026-11-16
GLTO
DAMORA THERAPEU...
Healthcare 0.00% 0.88%
Sold All 😨
(Was: #18)
0.0
—
-3,783,000 -100.0%
CLOSED
— $— 2026 Q1 13F Filing 2026-09-30 2026-11-16
Showing 1-31 of 31 holdings

Unlock Full Avoro Capital Advisors LLC Analysis

PRO subscribers get access to all historical quarters, Excel/CSV exports, Portfolio Concentration Analytics (PCA), and Risk-Based ENB.

Full Historical Quarters
Excel & CSV Export
PCA & Risk-Based ENB
Auto Cost Basis
Position Change Alerts
Price-Held Analytics
Full history →